Feed de notíciasFeed de notíciashttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/rss2026-06-10T12:36:17Z2026-06-10T12:36:17ZMydrane (Tropicamida + Fenilefrina + Lidocaína) | Relatório de avaliação de financiamento público disponível | Deferimento do pedido de avaliação préviaLuís Fonsecahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131326332026-06-09T15:59:44Z2026-06-09T13:45:00ZLuís Fonseca2026-06-09T13:45:00ZUE publica primeira Avaliação Clínica Conjunta ao abrigo do novo regulamento de avaliação de tecnologias de saúdeNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131311112026-06-09T15:40:46Z2026-06-09T10:04:00ZNuno Noronha2026-06-09T10:04:00ZCNFT lança novo boletim informativo para reforçar divulgação da sua atividadeNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131292052026-06-08T10:44:19Z2026-06-08T10:36:00ZNuno Noronha2026-06-08T10:36:00ZAtualização da lista de medicamentos cuja exportação é temporariamente suspensa - junho 2026laura leitehttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131289392026-06-08T10:32:57Z2026-06-08T08:20:00Zlaura leite2026-06-08T08:20:00ZAceda à mais recente edição da Infarmed NewsletterHugo Grilohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131265062026-06-05T15:03:11Z2026-06-05T15:00:00ZHugo Grilo2026-06-05T15:00:00ZAceda à nova edição da Infarmed NewsletterHugo Grilohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/119982942026-06-05T14:55:15Z2025-11-18T16:11:00ZHugo Grilo2025-11-18T16:11:00ZInfarmed encerra ciclo de <em>webinars</em> sobre tecnologias digitais na saúdeNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131238052026-06-05T10:44:55Z2026-06-05T09:48:00ZNuno Noronha2026-06-05T09:48:00ZIndisponibilidade do medicamento Tromalyt 150 mglaura leitehttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131234842026-06-05T10:11:01Z2026-06-05T08:22:00Zlaura leite2026-06-05T08:22:00ZGardasil 9 | Relatório de avaliação de financiamento público disponível | Indeferimento do pedido de comparticipaçãoLuís Fonsecahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131216642026-06-03T14:43:39Z2026-06-03T11:14:00ZLuís Fonseca2026-06-03T11:14:00ZInfarmed recebe visita de estudo do projeto europeu AUGMENT BiosimilarsNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131185082026-06-03T09:03:46Z2026-06-03T08:57:00ZNuno Noronha2026-06-03T08:57:00ZModelo de reporte trimestral de atividades de cultivo e fabrico de canábis para fins medicinaispaulo fernandeshttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/131157052026-06-01T12:17:02Z2026-06-01T11:21:00Zpaulo fernandes2026-06-01T11:21:00ZInfarmed abre novos concursos para cargos dirigentesNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130953642026-05-29T07:42:55Z2026-05-29T07:30:00ZNuno Noronha2026-05-29T07:30:00ZOmvoh (Miricizumab) na Doença de Crohn | Relatório de avaliação de financiamento público | Deferimento de avaliação préviapaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130851672026-05-28T18:41:24Z2026-05-26T11:15:00Zpaula pinheiro2026-05-26T11:15:00ZIqirvo (Elafibranor) | Relatório de avaliação de financiamento público | Desistência do pedido de avaliação préviapaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130866102026-05-28T18:35:29Z2026-05-27T09:45:00Zpaula pinheiro2026-05-27T09:45:00ZOperacionalização da EUDAMED e atualização do SIDMMiguel Dantashttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130929082026-05-28T14:49:08Z2026-05-28T14:40:00ZMiguel Dantas2026-05-28T14:40:00ZInfarmed divulga indicadores de abril de 2026Teresa Canelhashttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130923092026-05-28T14:43:53Z2026-05-28T14:33:00ZTeresa Canelhas2026-05-28T14:33:00ZVelsipity (Etrasimod) | Relatório de avaliação de financiamento público disponível | Deferimento de avaliação préviapaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130854012026-05-27T09:42:19Z2026-05-26T14:31:00Zpaula pinheiro2026-05-26T14:31:00ZPublicado relatório de financiamento público do medicamento Omvoh (Miricizumab) para Colite Ulcerosapaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130849752026-05-26T15:59:50Z2026-05-26T10:46:00Zpaula pinheiro2026-05-26T10:46:00ZComissão Europeia altera anexos do Regulamento de Produtos Cosméticos (UE 2026/909)Mariana Falcãohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130846412026-05-26T14:37:56Z2026-05-26T08:53:00ZMariana Falcão2026-05-26T08:53:00ZOperacionalização da EUDAMED a 28 de maio de 2026lina ribeirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/130566412026-05-25T10:57:27Z2026-05-20T16:38:00Zlina ribeiro2026-05-20T16:38:00Z